Search

everythinglearnresearchcommunity

for

Search:↓

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Immune therapy for cancer can cause hair loss scars in some patients.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

A microneedle patch can help regrow hair by restoring immune balance in hair follicles.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

Microneedle therapy combined with Hwangryeonhaedoktang solution improved hair growth in mice better than microneedle therapy alone.

ECM1-modified stem cells can effectively treat liver cirrhosis.

HS needs personalized treatment plans and more research.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Merkel cell carcinoma is most likely to recur within two years of diagnosis, and factors like immune suppression, being over 75, and male sex increase this risk.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Targeted therapy for skin cancer is complex due to the role of the hedgehog pathway in both cancer and hair growth.

Cimetidine did not reduce hair growth in women with hirsutism.

Mohs micrographic surgery is effective for treating basal cell carcinoma on the eyelid, while radiotherapy has higher recurrence rates, and topical vitamin D3 may reduce and delay BCC formation in mice.

The combination therapy significantly improved Riehl’s melanosis in patients without serious side effects.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Chemotherapy-induced hair loss may be linked to immune system changes, and certain treatments could help but need careful use.

A 73-year-old woman with Hypopigmented Mycosis Fungoides, a rare skin lymphoma, experienced disease progression despite treatment, emphasizing the need for ongoing monitoring.

CMV infection increases the risk of GvHD after bone marrow transplants.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.